Mechanism of Bax/Bak Activation During Apoptosis
细胞凋亡过程中 Bax/Bak 激活的机制
基本信息
- 批准号:10004152
- 负责人:
- 金额:$ 32.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:ApoptosisApoptoticAutoimmune DiseasesBCL-2 ProteinBCL2 geneBax proteinBiochemicalCell DeathCell physiologyCellsCellular biologyCessation of lifeConsensusDataDefectDevelopmentDiseaseEnsureFamilyGeneticGoalsHomeostasisIn VitroInterruptionKineticsKnock-outLifeLipidsMCL1 geneMalignant NeoplasmsMediatingMembraneMitochondriaModelingMolecularMutagenesisNerve DegenerationOuter Mitochondrial MembranePathologicPathway interactionsPlayProcessProtein FamilyProtein p53ProteinsPumaRegulationResearchRoleSignal PathwayStimulusStructureSubgroupTestingTherapeutic InterventionWorkbasecancer cellexperimental studygenome editinghuman diseaseinsightmembernew therapeutic targetnovelprogramstargeted treatmenttool
项目摘要
Apoptosis is an essential cellular death program that controls proper development and maintains homeostasis.
Aberrant regulation of apoptosis contributes to many diseases, such as neurodegeneration, autoimmune
diseases, and cancer. The mitochondria-dependent pathway is a major apoptotic pathway, and is primarily
regulated and executed by the Bcl-2 family proteins. The Bcl-2 family includes five anti-apoptotic members, two
effector proteins Bax and Bak, and eight pro-apoptotic BH3-only proteins. They control the mitochondrial
pathway at the step of mitochondrial outer membrane permeabilization (MOMP), a central control point leading
to apoptosis. Our long term goal is to elucidate the signaling pathways and molecular mechanisms
responsible for mitochondria-dependent apoptosis, and provide positive impact on the development of more
potent and specific therapies against apoptosis-related diseases. While genetic and biochemical studies have
long established the role of Bax and Bak as two essential effectors of MOMP, the mechanism of Bax/Bak
activation, commonly considered the life-to-death switch of the cells, has been intensively investigated in the
past two decades. The current consensus is that while all pro-apoptotic BH3-only proteins suppress the anti-
apoptotic Bcl-2 proteins, a subset of BH3-only proteins directly engage and activate Bax and Bak during
apoptosis. However, in our preliminary studies, we provide genetic evidence suggesting that such a BH3-only
protein-mediated direct activation is not necessary for Bax/Bak activation and apoptosis. Instead, our results
suggest that upon the BH3-only protein-mediated neutralization of the anti-apoptotic Bcl-2 proteins, Bax/Bak
undergo a membrane-dependent, spontaneous activation process. Based on our preliminary studies, we
propose a new model of Bax/Bak activation, which will be examined primarily by genetics, cell biology, and
biochemical approaches. The following three Aims are proposed. In Aim 1, we will examine the role of the
BH3-only proteins and other potential direct activators in Bax/Bak activation following the inactivation of anti-
apoptotic Bcl-2 proteins. In Aim 2, we will investigate the involvement of mitochondrial outer membrane in the
regulation of Bax/Bak activation. In Aim 3, we will investigate the mechanism of anti-apoptotic Bcl-2 protein-
mediated suppression of the Bax/Bak activation. Overall, our proposed studies are expected to elucidate the
mechanism of Bax/Bak activation during apoptosis. This proposal may not only unravel one of the long
standing mysteries in apoptosis research, but also provide novel targets for therapeutic intervention.
细胞凋亡是控制正常发育和维持体内平衡的重要细胞死亡程序。
细胞凋亡的异常调节会导致许多疾病,例如神经退行性疾病、自身免疫性疾病
疾病和癌症。线粒体依赖性途径是主要的细胞凋亡途径,并且主要是
由 Bcl-2 家族蛋白调节和执行。 Bcl-2家族包括五个抗凋亡成员,两个
效应蛋白 Bax 和 Bak,以及八种促凋亡 BH3 蛋白。它们控制线粒体
线粒体外膜透化(MOMP)步骤中的途径,是导致线粒体外膜透化的中央控制点
至细胞凋亡。我们的长期目标是阐明信号通路和分子机制
负责线粒体依赖性细胞凋亡,并对更多细胞的发育产生积极影响
针对细胞凋亡相关疾病的有效且特异性的疗法。虽然遗传和生化研究已经
长期以来确立了Bax和Bak作为MOMP的两个重要效应器的作用,Bax/Bak的机制
激活通常被认为是细胞的生死转换,已在
过去二十年。目前的共识是,虽然所有促凋亡 BH3 蛋白都会抑制抗凋亡蛋白
凋亡 Bcl-2 蛋白是仅 BH3 蛋白的一个子集,在凋亡过程中直接参与并激活 Bax 和 Bak
细胞凋亡。然而,在我们的初步研究中,我们提供了遗传证据表明这种仅 BH3
Bax/Bak 激活和细胞凋亡不需要蛋白质介导的直接激活。相反,我们的结果
表明仅 BH3 蛋白介导的抗凋亡 Bcl-2 蛋白的中和作用,Bax/Bak
经历膜依赖性自发激活过程。根据我们的初步研究,我们
提出了一种新的 Bax/Bak 激活模型,该模型将主要通过遗传学、细胞生物学和
生化方法。提出以下三个目标。在目标 1 中,我们将研究
BH3-only 蛋白和其他潜在的直接激活剂在抗-Bax/Bak 失活后激活
凋亡 Bcl-2 蛋白。在目标 2 中,我们将研究线粒体外膜在
Bax/Bak 激活的调节。在目标3中,我们将研究Bcl-2蛋白的抗凋亡机制——
介导的 Bax/Bak 激活抑制。总的来说,我们提出的研究预计将阐明
细胞凋亡过程中 Bax/Bak 激活的机制这一提议不仅可能解开长期存在的问题之一
细胞凋亡研究中长期存在的谜团,但也为治疗干预提供了新的靶点。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
MARCH5-dependent degradation of MCL1/NOXA complexes defines susceptibility to antimitotic drug treatment.
MCL1/NOXA 复合物的 MARCH5 依赖性降解决定了抗有丝分裂药物治疗的敏感性。
- DOI:
- 发表时间:2020-08
- 期刊:
- 影响因子:12.4
- 作者:Haschka, Manuel D;Karbon, Gerlinde;Soratroi, Claudia;O'Neill, Katelyn L;Luo, Xu;Villunger, Andreas
- 通讯作者:Villunger, Andreas
Venetoclax causes metabolic reprogramming independent of BCL-2 inhibition.
Venetoclax 可引起独立于 BCL-2 抑制的代谢重编程。
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:9
- 作者:Roca;Rodriguez;Sumpton, David;Cloix, Catherine;Mullin, Margaret;Mackay, Gillian M;O'Neill, Katelyn;Lemgruber, Leandro;Luo, Xu;Tait, Stephen W G
- 通讯作者:Tait, Stephen W G
Hexokinases inhibit death receptor-dependent apoptosis on the mitochondria.
己糖激酶抑制线粒体上死亡受体依赖性细胞凋亡。
- DOI:
- 发表时间:2021
- 期刊:
- 影响因子:11.1
- 作者:Lauterwasser, Joachim;Fimm;Oelgeklaus, Aline;Schreiner, Annabell;Funk, Kathrin;Falquez;Klesse, Ramona;Jahreis, Günther;Zerbes, Ralf M;O'Neill, Katelyn;van der Laan, Martin;Luo, Xu;Edlich, Frank
- 通讯作者:Edlich, Frank
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xu Luo其他文献
Xu Luo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xu Luo', 18)}}的其他基金
Mechanism of Bax/Bak Activation During Apoptosis
细胞凋亡过程中 Bax/Bak 激活的机制
- 批准号:
9379973 - 财政年份:2017
- 资助金额:
$ 32.03万 - 项目类别:
FUNCTIONAL HOMOLOGY BETWEEN ACTIVE BAX AND BACTERIOPHAGE HOLIN
活性 BAX 和噬菌体 Holin 之间的功能同源性
- 批准号:
8360445 - 财政年份:2011
- 资助金额:
$ 32.03万 - 项目类别:
COBRE: UNE MED CTR PILOT2: MECHANISM OF BAX ACTIVATION DURING APOPTOSIS
COBRE:UNE MED CTR PILOT2:细胞凋亡期间 BAX 激活机制
- 批准号:
7382060 - 财政年份:2006
- 资助金额:
$ 32.03万 - 项目类别:
相似国自然基金
RIPK1泛素化修饰介导MLKL调控隐窝基底柱状细胞坏死性凋亡在脓毒症肠损伤中的机制研究
- 批准号:82302477
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
局灶节段硬化性肾小球肾炎中FSTL3通过DC-SIGN促足细胞凋亡的作用研究
- 批准号:82300796
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Foxo3通过ROS介导的氧化应激和凋亡双向调控和厚朴酚神经效-毒作用的机制研究
- 批准号:82304639
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
凋亡小体通过ACKR3介导巨噬细胞重编程对狼疮的疗效及机制研究
- 批准号:82302053
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SIRT2/Annexin A2/autophagy通路形成的分子机制及其在HCC细胞失巢凋亡抵抗中的作用研究
- 批准号:32300626
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
C/EBPβ Regulation of the Type 1 IFN Response; Sensitizing Keratinocytes to Direct Activators of Cytosolic PRRs and DNA Damage-Induced Cell Death
C/EBPβ 1 型干扰素反应的调节;
- 批准号:
10735531 - 财政年份:2023
- 资助金额:
$ 32.03万 - 项目类别:
Thymic selection abnormalities in Type 1 Diabetes
1 型糖尿病的胸腺选择异常
- 批准号:
10717714 - 财政年份:2023
- 资助金额:
$ 32.03万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 32.03万 - 项目类别:
Beta Cell Heterogeneity in the Interferon Alpha Response
干扰素α反应中的β细胞异质性
- 批准号:
10751684 - 财政年份:2023
- 资助金额:
$ 32.03万 - 项目类别: